Released on: March 13, 2008, 4:20 pm

Press Release Author: GTC Bio

Industry: Pharmaceuticals

Press Release Summary: GTCbio just announced its holding the annual Modern Drug
Discovery and Development Summit taking place on October 15-17, 2008 in San Diego,
CA.

Now in its fourth year, the summit will once again provide a landscape and in-depth
industry analysis streaming through different therapeutic and target areas and
examining the current advancements and where we're headed in the coming years.


Press Release Body: The M3D summit will include 6 full conference tracks, 3 short
symposia, and 6 mini stand-alone sessions. The individual tracks will focus on
biological therapeutics, translational medicine, drug design & lead discovery,
emerging targets & therapeutics, pharmacokinetics & pharmacodynamics, and
partnering, licensing & outsourcing. The 3 short symposia taking place the first
morning of the summit will feature presentations on stem cells as tools for drug
discovery, imaging technologies, and regulatory updates in the industry.

Leading presenters from all over the world will come to San Diego to discuss the
outlook of the biopharmaceutical market place. Presenting organizations include,
Pfizer, Merck, Novartis, Eli Lilly, GSK, Aventis, Genentech, Amgen, Biogen Idec,
NIH, FDA & many more.

For more information on speaking, presenting a poster, or sponsoring, please visit
www.gtcbio.com.


Web Site: http://www.gtcbio.com

Contact Details: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com